259 related articles for article (PubMed ID: 29405306)
21. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.
Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C
Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526
[TBL] [Abstract][Full Text] [Related]
22. [Evolution of residual risk for HIV, HCV and HBV, from 1999 to 2010, in blood donations of the Centro Hospitalar S. João, EPE, Porto, Portugal].
Koch C; Araújo F
Acta Med Port; 2013; 26(4):371-6. PubMed ID: 24016646
[TBL] [Abstract][Full Text] [Related]
23. [Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)].
Pillonel J; Laperche S; ; ;
Transfus Clin Biol; 2004 Apr; 11(2):81-6. PubMed ID: 15120104
[TBL] [Abstract][Full Text] [Related]
24. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.
Zou S; Dodd RY; Stramer SL; Strong DM;
N Engl J Med; 2004 Aug; 351(8):751-9. PubMed ID: 15317888
[TBL] [Abstract][Full Text] [Related]
25. Two decades of risk factors and transfusion-transmissible infections in Dutch blood donors.
Slot E; Janssen MP; Marijt-van der Kreek T; Zaaijer HL; van de Laar TJ
Transfusion; 2016 Jan; 56(1):203-14. PubMed ID: 26355711
[TBL] [Abstract][Full Text] [Related]
26. Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa.
Kania D; Bekalé AM; Nagot N; Mondain AM; Ottomani L; Meda N; Traoré M; Ouédraogo JB; Ducos J; Van de Perre P; Tuaillon E
Clin Microbiol Infect; 2013 Dec; 19(12):E533-41. PubMed ID: 23902574
[TBL] [Abstract][Full Text] [Related]
27. Blood donors' positivity for transfusion-transmissible infections: the Serbian Military Medical Academy experience.
Vučetić D; Kecman G; Ilić V; Balint B
Blood Transfus; 2015 Oct; 13(4):569-75. PubMed ID: 26057495
[TBL] [Abstract][Full Text] [Related]
28. Red blood cells treated with the amustaline (S-303) pathogen reduction system: a transfusion study in cardiac surgery.
Brixner V; Kiessling AH; Madlener K; Müller MM; Leibacher J; Dombos S; Weber I; Pfeiffer HU; Geisen C; Schmidt M; Henschler R; North A; Huang N; Mufti N; Erickson A; Ernst C; Rico S; Benjamin RJ; Corash LM; Seifried E
Transfusion; 2018 Apr; 58(4):905-916. PubMed ID: 29498049
[TBL] [Abstract][Full Text] [Related]
29. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
30. Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion.
Feys HB; Van Aelst B; Devreese K; Devloo R; Coene J; Vandekerckhove P; Compernolle V
Vox Sang; 2014 May; 106(4):307-15. PubMed ID: 24460692
[TBL] [Abstract][Full Text] [Related]
31. The prevalence of transfusion-transmitted infections and nucleic acid testing among blood donors in Majmaah, Saudi Arabia.
Alaidarous M; Choudhary RK; Waly MI; Mir S; Bin Dukhyil A; Banawas SS; Alshehri BM
J Infect Public Health; 2018; 11(5):702-706. PubMed ID: 29703711
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B and blood safety.
Kitchen A
Vaccine; 1998 Nov; 16 Suppl():S34-7. PubMed ID: 9915031
[TBL] [Abstract][Full Text] [Related]
33. Blood transfusion practice in a rural hospital in Northern Ghana, Damongo, West Gonja District.
Kubio C; Tierney G; Quaye T; Nabilisi JW; Ziemah C; Zagbeeb SM; Shaw S; Murphy WG
Transfusion; 2012 Oct; 52(10):2161-6. PubMed ID: 22612858
[TBL] [Abstract][Full Text] [Related]
34. Reduction of the risk of transfusion-transmitted viral infection by nucleic acid amplification testing in the Western Cape of South Africa: a 5-year review.
Cable R; Lelie N; Bird A
Vox Sang; 2013 Feb; 104(2):93-9. PubMed ID: 22924987
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study.
Farshadpour F; Taherkhani R; Tajbakhsh S; Gholizadeh Tangestani M; Hajiani G; Sharifi N; Taherkhani S; Nejadbolkheyr A
PLoS One; 2016; 11(6):e0157615. PubMed ID: 27309959
[TBL] [Abstract][Full Text] [Related]
36. The transfusion-transmitted viruses in blood transfusion.
Luban NL; Jubran RF
Adv Exp Med Biol; 2001; 489():1-12. PubMed ID: 11554584
[No Abstract] [Full Text] [Related]
37. Web interface-supported transmission risk assessment and cost-effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands.
van Hulst M; Hubben GA; Sagoe KW; Promwong C; Permpikul P; Fongsatitkul L; Glynn DM; Sibinga CT; Postma MJ
Transfusion; 2009 Dec; 49(12):2729-42. PubMed ID: 19709093
[TBL] [Abstract][Full Text] [Related]
38. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates.
Kane A; Lloyd J; Zaffran M; Simonsen L; Kane M
Bull World Health Organ; 1999; 77(10):801-7. PubMed ID: 10593027
[TBL] [Abstract][Full Text] [Related]
39. Overview: diagnostic tests for viral infections transmitted by blood.
Holland PV
Nucl Med Biol; 1994 Apr; 21(3):407-17. PubMed ID: 9234305
[TBL] [Abstract][Full Text] [Related]
40. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review.
Simonsen L; Kane A; Lloyd J; Zaffran M; Kane M
Bull World Health Organ; 1999; 77(10):789-800. PubMed ID: 10593026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
